Effect of N-acetyl cysteine on controling clinical symtoms and inflammatory biomarkers in rhumatoid arthritis Patients
Phase 2
- Conditions
- Rheumatoid arthritis.Rheumatoid arthritis, unspecified
- Registration Number
- IRCT2015071722965N2
- Lead Sponsor
- Vice chancellor for research, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Patients with diagnosis of arthritis rhumatoid; Patients more than 18 years and less than 65 years; Patients with moderate to severe active disease
Exclusion criteria: Patients with active infection; Patients with mild active disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IL-6,TNF-alfa. Timepoint: Baseline, after 12 months. Method of measurement: serum level.
- Secondary Outcome Measures
Name Time Method Assesment of clinical symptoms. Timepoint: Baseline, after 12 months. Method of measurement: Disease Activity Score, version 28 questionnaire.